"What" Series

What is ICH in Life Sciences?

28 September 2023
2 min read

The full name is the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, which is an international coordinating organization initiated in 1990 by the pharmaceutical regulatory authorities and the pharmaceutical industry management agencies of Europe, Japan, and the United States. They aim to harmonize the existing differences in the technical regulations for the registration of pharmaceuticals for human use in these three regions. The main goal is to accelerate the research and development and market launch of new drugs worldwide without affecting the quality, safety, and effectiveness of the drugs.

Hepagene Therapeutics Confirms FDA Approval of Experimental New Drug Application (IND) for HPG7233 THR Beta Stimulant
Latest Hotspot
3 min read
Hepagene Therapeutics Confirms FDA Approval of Experimental New Drug Application (IND) for HPG7233 THR Beta Stimulant
28 September 2023
Hepagene Therapeutics revealed that its IND application forHPG7233 has been approved by the FDA in the United States.
Read →
Deep Scientific Insights on Sodium Salicylate's R&D Progress, Mechanism of Action, and Drug Target
Drug Insights
4 min read
Deep Scientific Insights on Sodium Salicylate's R&D Progress, Mechanism of Action, and Drug Target
1 October 2023
This article summarized the latest R&D progress of Sodium Salicylate, the Mechanism of Action for Sodium Salicylate, and the drug target R&D trends for Sodium Salicylate.
Read →
The Application of CAR-T in Multiple Myeloma
Advanced Tech.
7 min read
The Application of CAR-T in Multiple Myeloma
28 September 2023
Currently, CAR-T therapy has promising potential in the field of multiple myeloma treatment.
Read →
An In-depth Analysis of Tolbutamide's R&D Progress and Mechanism of Action on Drug Target
Drug Insights
4 min read
An In-depth Analysis of Tolbutamide's R&D Progress and Mechanism of Action on Drug Target
30 September 2023
This article summarized the latest R&D progress of Tolbutamide, the Mechanism of Action for Tolbutamide, and the drug target R&D trends for Tolbutamide.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.